Tag: announced-the-signing

Astellas Pharma, MD Anderson sign option agreement to research and develop new treatment for AML

| April 6, 2015 | 0 Comments

Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center today announced the signing of an option agreement to research and develop a new treatment for patients with acute myeloid leukemia (AML).

Continue Reading

Global Cancer Diagnostics Grants First International License for The Lung Cancer Test™ to Bertech Pharma Ltd.

| January 8, 2015 | 0 Comments

PHOENIX, Jan. 8, 2015 /PRNewswire/ — Global Cancer Diagnostics Inc.

Continue Reading

iCAD Acquires DermEbx and Radion to Provide Powerful Comprehensive Skin Cancer Treatment Solution to the Dermatology …

| July 15, 2014 | 0 Comments

iCAD, Inc. , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced the signing of a definitive agreement to acquire DermEbx™, a leading electronic brachytherapy services and technology provider, and Radion, Inc., a cloud-based oncology collaboration software solution.

Continue Reading